Glaucoma, a leading cause of irreversible blindness, is associated with elevated pressure in the eye. This elevated pressure essentially is due to a plumbing problem. Fluid builds up in the eye, increasing pressure and eventually damaging the optic nerve. For nearly 150 years, researchers have been trying to understand what causes the blockage that prevents the eye from draining properly.
In a unique study of human ocular cells, a multi-institution research team led by a biomedical engineer at Northwestern University has found a new culprit. Glaucoma appears to be a consequence of mechanical dysfunction of endothelial cells, a thin layer of cells that is the final barrier to fluid entering Schlemm’s canal, from which fluid then drains from the eye.
The researchers found that these endothelial cells from eyes with glaucoma are stiffer than cells from healthy eyes. This stiffness limits the cells’ ability to deform and allow a fluid called aqueous humor to cross the endothelium and drain into Schlemm’s canal. This increased flow resistance is responsible for the elevated pressure associated with glaucoma. The findings were published in the journal Proceedings of the National Academy of Sciences (PNAS).
There is no cure for glaucoma, which affects more than two million Americans. This seminal work shows that cells of this endothelial layer act as mechanical gates. Therapeutic strategies that alter the stiffness of these cells potentially could lead to a cure for this debilitating disease.
Both Schlemm’s canal and the clear aqueous humor it drains from the eyeball are vital to the eye’s health and function. The aqueous humor nourishes the eye and maintains its proper pressure. Aqueous humor from the eye’s anterior chamber (located between the iris and cornea) collects in the canal from which it then flows into the vascular system. If the endothelial cells lining Schlemm’s canal are too stiff, it is difficult for them to form pores that allow the aqueous humor to pass through this thin layer and drain into the canal. Pressure then increases in the eye and eventually causes damage to the optic nerve at the back of the eye.
The work is one of the first times that the methods of mechanobiology, the study of the mechanical characteristics of cells, have been used to show that dysfunctional cell mechanics lies at the heart of a disease process.
Source: Northwestern University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.